U. Ekstrom et al., PHENOTYPIC-EXPRESSION OF AUTOSOMAL-DOMINANT RETINITIS-PIGMENTOSA IN ASWEDISH FAMILY EXPRESSING A PHE-211-LEU VARIANT OF PERIPHERIN RDS/, Ophthalmic genetics, 19(1), 1998, pp. 27-37
Purpose: To characterize the clinical phenotype, with emphasis on elec
trophysiology, of members of a Swedish family with autosomal dominant
retinitis pigmentosa due to a novel mutation, F211L, in the peripherin
/RDS gene. Methods: Nine patients with autosomal dominant retinitis pi
gmentosa and two healthy family members underwent a full clinical eval
uation including kinetic visual field testing, measurement of dark ada
ptation threshold, and full-field electroretinography. Blood samples w
ere collected and DNA analysis was performed using denaturing gradient
gel electrophoresis (DGGE). Results: The grandfather, six of seven si
blings from the middle generation, and two young boys carried the muta
tion F211L in the peripherin/RDS gene. The mutation segregated with th
e clinical presentation of disease. Fundus examination revealed mainly
macular atrophy. All assessed parameters of retinal function (visual
acuity, dark adaptation threshold, visual fields, and full-field elect
roretinograms) demonstrated a successive reduction with increasing age
. Full-field electroretinograms showed a diminished rod response in al
l affected individuals and a reduction of the cone b-wave amplitudes w
ith increasing age, indicating retinitis pigmentosa. In the affected f
amily members, the disease seems to progress at a similar rate with in
creasing age. Conclusions: The peripherin/RDS gene mutation F211L is a
ssociated with a clinical phenotype and includes early loss of rod fun
ction and successive reduction of cone function with increasing age, b
ut impressively well-preserved visual acuity and visual fields in youn
g and middle-aged patients and moderately reduced vision in the old pa
tient, Compared to previously described phenotypes segregating with mu
tations in the peripherin/RDS gene. the present family demonstrates a
more benign clinical phenotype, which is concordant within the family.